Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Vorinostat × Clear all

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer